Vasoactive Intestinal Peptide Secreting Tumors: Report of 1 Case and Retrospective Analysis of Data in Literatures_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 岳鵬舉 , 蘇安平 , 張懿 , 楊敏 , 王力 ,  田伯樂

四川大學華西醫院胰腺外科（四川成都 610041）;

Corresponding?author：

田伯樂, Email: bo-le@medmail.com.cn

Keywords：

胰腺神經內分泌腫瘤; 血管活性腸肽; 血管活性腸肽瘤

DOI：

10.7507/1007-9424.20140118

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

目的探討胰腺血管活性腸肽瘤（VIPoma）的臨床、實驗室和影像學特點，以及診斷方法和治療手段。方法報道1例胰腺VIPoma，同時檢索國內文獻得到49例胰腺VIPoma患者臨床資料，并對此50例病例進行分析。結果分泌性腹瀉、低血鉀和代謝性酸中毒是胰腺VIPoma的主要臨床表現，血漿血管活性腸肽（VIP）水平增高具有診斷價值。經手術治療，腹瀉癥狀可減輕或消失；對于遠處轉移患者，生長抑素、化療、干擾素等治療均有效。結論 VIPoma早期診斷困難，確診依賴于典型臨床癥狀、血漿VIP水平、影像學檢查以及免疫組化檢查。手術切除可改善預后，生長抑素等治療可緩解癥狀，發生轉移者也應積極治療。

Citation： 岳鵬舉, 蘇安平, 張懿, 楊敏, 王力, 田伯樂. Vasoactive Intestinal Peptide Secreting Tumors: Report of 1 Case and Retrospective Analysis of Data in Literatures. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2014, 21(4): 488-491. doi: 10.7507/1007-9424.20140118 Copy

1.	Amir A, Ghaferi KA, Chojnacki WD, et al. Pancreatic VIPomas:subject review and one institutional experience[J]. J Gastrointest Surg, 2008, 12(2):382-393.
2.	Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory diarrhoea and hypokalemia[J]. Am J Med, 1958, 25(3):374-380.
3.	陳家偉, 何戎華, 薛婉芬.胰性霍亂[J].中華內科雜志, 1977, 2(6):387-388.
4.	王祖森, 吳力群, 赫建帥, 等.胰腺血管活性腸肽瘤1例報告暨國內文獻復習[J].中國普通外科雜志, 2010, 19(3):330-332.
5.	Kane MG, O'Dorisio TM, Krejs GJ. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide[J]. N Engl J Med, 1983, 309(24):1482-1485.
6.	Cynthia Ro, Wanxing Chai, Victoria E. Yu, et al. Pancreatic neuroendocrine tumors:biology, diagnosis, and treatment[J]. Chin J Cancer, 2013, 32(6):312-324.
7.	Adam N, Lim SS, Ananda V, et al. VIPoma syndrome:challen-ges in management[J]. Singapore Med J, 2010, 51(7):e129-e132.
8.	Brunt LM, Mazoujian G, O'Dorisio TM, et al. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome[J]. Surgery, 1994, 115(3):362-369.
9.	Legmann P, Vignaux O'Dousset B, et al. Pancreatic tumors:comparison of dual-phase helical CT and endoscopic sonography[J]. Am J Roentgenol, 1998, 170(5):1315-1322.
10.	Sofka CM, Semelka RC, Marcos HB, et al. MR imaging of metastatic pancreatic VIPoma[J]. Magn Reson Imaging, 1997, 15(10):1205-1208.
11.	Thomason JW, Martin RS, Fincher ME. Somatostatin receptor scintigraphy:the definitive technique for characterizing vasoactive intestinal peptide-secreting tumors[J]. Clin Nucl Med, 2000, 25(9):661-664.
12.	Nikou GC, Toubanakis C, Nikolaou P, et al. VIPomas:an update in diagnosis and management in a series of 11 patients[J]. Hepatogastroenterology, 2005, 52(64):1259-1265.
13.	Remme CA, de Groot GH, Schrijver G. Diagnosis and treatment of VIPoma in a female patient[J]. Eur J Gastroenterol Hepatol, 2006, 18(1):93-99.
14.	Kulke MH, Anthony LB, Bushnell DL, et al. NANETS treatment guidelines:well-differentiated neuroendocrine tumors of the stomach and pancreas[J]. Pancreas, 2010, 39(6):735-752.
15.	Shaib W, Mitchell K, Saif MW. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma[J]. Yale J Biol Med, 2010, 83(1):27-33.
16.	Johnston PC, Ardill JE, Johnston BT, et al. Vasoactive intestinal polypeptide secreting pancreatic tumour with hepatic metastases:long term survival after orthotopic liver transplantation[J]. Ir J Med Sci, 2010, 179(3):439-441.
17.	Soga J, Yakuwa Y. VIPoma/diarrheogenic syndrome:a statistical evaluation of 241 reported cases[J]. J Exp Clin Cancer Res, 1998, 17(4):389-400.

1. Amir A, Ghaferi KA, Chojnacki WD, et al. Pancreatic VIPomas:subject review and one institutional experience[J]. J Gastrointest Surg, 2008, 12(2):382-393.
2. Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory diarrhoea and hypokalemia[J]. Am J Med, 1958, 25(3):374-380.
3. 陳家偉, 何戎華, 薛婉芬.胰性霍亂[J].中華內科雜志, 1977, 2(6):387-388.
4. 王祖森, 吳力群, 赫建帥, 等.胰腺血管活性腸肽瘤1例報告暨國內文獻復習[J].中國普通外科雜志, 2010, 19(3):330-332.
5. Kane MG, O'Dorisio TM, Krejs GJ. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide[J]. N Engl J Med, 1983, 309(24):1482-1485.
6. Cynthia Ro, Wanxing Chai, Victoria E. Yu, et al. Pancreatic neuroendocrine tumors:biology, diagnosis, and treatment[J]. Chin J Cancer, 2013, 32(6):312-324.
7. Adam N, Lim SS, Ananda V, et al. VIPoma syndrome:challen-ges in management[J]. Singapore Med J, 2010, 51(7):e129-e132.
8. Brunt LM, Mazoujian G, O'Dorisio TM, et al. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome[J]. Surgery, 1994, 115(3):362-369.
9. Legmann P, Vignaux O'Dousset B, et al. Pancreatic tumors:comparison of dual-phase helical CT and endoscopic sonography[J]. Am J Roentgenol, 1998, 170(5):1315-1322.
10. Sofka CM, Semelka RC, Marcos HB, et al. MR imaging of metastatic pancreatic VIPoma[J]. Magn Reson Imaging, 1997, 15(10):1205-1208.
11. Thomason JW, Martin RS, Fincher ME. Somatostatin receptor scintigraphy:the definitive technique for characterizing vasoactive intestinal peptide-secreting tumors[J]. Clin Nucl Med, 2000, 25(9):661-664.
12. Nikou GC, Toubanakis C, Nikolaou P, et al. VIPomas:an update in diagnosis and management in a series of 11 patients[J]. Hepatogastroenterology, 2005, 52(64):1259-1265.
13. Remme CA, de Groot GH, Schrijver G. Diagnosis and treatment of VIPoma in a female patient[J]. Eur J Gastroenterol Hepatol, 2006, 18(1):93-99.
14. Kulke MH, Anthony LB, Bushnell DL, et al. NANETS treatment guidelines:well-differentiated neuroendocrine tumors of the stomach and pancreas[J]. Pancreas, 2010, 39(6):735-752.
15. Shaib W, Mitchell K, Saif MW. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma[J]. Yale J Biol Med, 2010, 83(1):27-33.
16. Johnston PC, Ardill JE, Johnston BT, et al. Vasoactive intestinal polypeptide secreting pancreatic tumour with hepatic metastases:long term survival after orthotopic liver transplantation[J]. Ir J Med Sci, 2010, 179(3):439-441.
17. Soga J, Yakuwa Y. VIPoma/diarrheogenic syndrome:a statistical evaluation of 241 reported cases[J]. J Exp Clin Cancer Res, 1998, 17(4):389-400.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Vasoactive Intestinal Peptide Secreting Tumors: Report of 1 Case and Retrospective Analysis of Data in Literatures

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content